Special Section on Implications of CATIE: Who Are the New Users of Antipsychotic Medications?
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective-to examine changes in the prevalence of antipsychotic medication use and the characteristics of antipsychotic users in the US population.Methods-We use data from the Medical Expenditure Panel Survey from 1996/97 and 2004/05 to examine the rate of first and second-generation antipsychotic medication use and changes in the characteristics of users of all ages.We examine trends in the level of use by antipsychotic users both in terms of daily dose units and number of prescriptions.Results-The rate of antipsychotic use has increased substantially between 1996/97 and 2004/05, but the average dose measured both by daily dose units and number of prescriptions has remained constant.The rapid diffusion of antipsychotic medications occurred not among individuals with schizophrenia, but rather includes substantial growth in off-label users and newer on-label conditions.Demographic, financial, and insurance characteristics of users have remained fairly constant, with few exceptions.The average age of antipsychotic users has declined from 1996-2005 as more children are using these medications.The gender, racial, ethnic, and insurance composition of users has been fairly stable over time, however. Conclusions-The rapid diffusion of second-generation antipsychotic medications was achieved by large increases in the rate of use in certain subpopulations, most notably children.Increasing understanding of the marginal efficacy and side-effect risks of newer and more expensive antipsychotic agents, even when prescribed as indicated, suggests that the dramatic increase in use warrants careful attention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Self-citationSchneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
Off-label prescribing among office-based physicians
Radley, D. C., Finkelstein, S. N., & Stafford, R. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.9.1021 · Cited by 711
Antipsychotics in Children and Adolescents
CAMPBELL, M., RAPOPORT, J. L., & SIMPSON, G. M. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199905000-00015 · Cited by 113
Cited by
International Consensus Study of Antipsychotic Dosing
Gardner, D. M., Murphy, A. L., O'Donnell, H., Centorrino, F., & Baldessarini, R. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09060802 · Cited by 1,301
Increasing off‐label use of antipsychotic medications in the United States, 1995–2008
Alexander, G. C., Gallagher, S. A., Mascola, A., Moloney, R. M., & Stafford, R. S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2082 · Cited by 423
National Trends in Outpatient Psychotherapy
Olfson, M., & Marcus, S. C. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10040570 · Cited by 315
Review of the operational definition for first‐episode psychosis
Breitborde, N. J. K., Srihari, V. H., & Woods, S. W. (2009) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2009.00148.x · Cited by 282
Martin, B. C., Wiley-Exley, E. K., Richards, S., Domino, M. E., Carey, T. S., & Sleath, B. L. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1k671 · Cited by 226
Self-citation
Metadata
- Authors
- Domino, M. E., & Swartz, M. S.
- Venue
- Psychiatric Services
- Published
- 2008-05
- Volume
- 59
- Issue
- 5
- Pages
- 507-514
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2097436876
- Cited by
- 79
- References
- 4
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.